The global sales of women digital health solutions is estimated to be worth USD 2,935.9 million in 2024 and anticipated to reach a value of USD 9,618.9 million by 2034. Sales are projected to rise at a CAGR of 12.6% over the forecast period between 2024 and 2034. The revenue generated by Atopic Dermatitis Treatment cover in 2023 was USD 2,607.4 million. The industry is anticipated to exhibit a Y-o-Y growth of 12.8% in 2024.
Digital health solutions for women are also called Femtech, which looks after the specific and unique needs that women have in healthcare. Women's health is a broad industry that includes a variety of products, services, equipment, diagnostics solutions, and others, that cater to special female needs such as reproductive health, menstrual care, fertility tracking, pregnancy monitoring, and postpartum support.
In addition, FemTech also involves developing solutions for chronic conditions that affect specifically women such as endometriosis and polycystic ovary syndrome. The solutions in FemTech are driven by the growing adoption of mobile apps, wearables, and artificial intelligence.
Women Digital Health Solutions Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 2,607.4 million |
| Estimated Size, 2024 | USD 2,935.9 million |
| Projected Size, 2034 | USD 9,618.9 million |
| Value-based CAGR (2024 to 2034) | 12.6% |
The government initiatives and support are instrumental in driving the growth of the Women Digital Health Solution Market. More and more, governments worldwide are recognizing the key role of addressing women's health issues by supporting the creation and adoption of digital health solutions to meet such needs.
Governments are supporting this sector primarily through funding and grants. For example, the USA Department of Health and Human Services has allocated substantial resources to support digital health initiatives, particularly in areas concerning women's health.
In 2022 alone, HHS announced a grant of USD 4.5 million to recipients who would further continue to work on telehealth services in times of prenatal and postpartum care due to its sensitivity to a woman's life. Similarly, the European Union’s Horizon Projects 2020 aims to focus on digital menopausal management, reproductive health, and other issues related to women's health.
Besides providing funds, the governments are also playing a vital role in offering favorable regulatory environments. For example, the USA FDA has already streamlined the approval process of digital health applications, especially those on women's health.
The Digital Health Innovation Action Plan initiated by the FDA has within its provisions hastened the review and approval of applications developed through FemTech and targeting female health needs.
While the market is experiencing growth there persist certain challenges such as lack of accessibility in rural areas and risk to data security and privacy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global women digital health solutions market's compound annual growth rate (CAGR) for the first half of 2023 and 2024 is compared in the table below. This analysis provides important insights into the performance of the industry by highlighting significant shifts and trends in revenue generation.
The first half (H1) is the period from January to June, and the second half (H2) is July to December. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to grow at a CAGR of 13.4%, followed by a slightly lower growth rate of 13.0% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 13.4% (2023 to 2033) |
| H2 | 13.0% (2023 to 2033) |
| H1 | 12.6% (2024 to 2034) |
| H2 | 12.1% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 12.6% in the first half and remain relatively moderate at 12.1% in the second half. In the first half (H1) the industry witnessed a decrease of 80 BPS while in the second half (H2), the industry witnessed a decrease of 90 BPS
Growing Awareness of Women's Health Drive Women Digital Health Solutions Market
The awareness of women's health acts as a driver in the women's digital health solution market. Greater educational campaigns, larger media exposure, and efforts by nonprofits organizations to underline problems related to women's health, including those about reproductive health, maternal care, and chronic diseases like breast cancer and osteoporosis, are some of the major factors contributing to fuel awareness.
Probably the most relevant example is the international drive for awareness of breast cancer, which is widely observed through events such as Breast Cancer Awareness Month, held in October month every year.
This increased awareness has translated into more funding of research, early detection programs, and the development of digital tools such as mammography tracking apps and artificial intelligence-based diagnostic platforms.
Companies like iBreastExam have developed portable, radiation-free devices that can be utilized in resource-poor settings to identify abnormalities of the breast and expand care to those women who may not have access to traditional healthcare facilities.
This growing awareness not only empowers women to take control of their health but also drives demand for innovative digital health solutions that cater specifically to their needs, propelling the market forward.
Rapid smartphone penetration drives the market’s growth
The increasing smartphone penetration acts as a strong driver in the market for women digital health solutions, granting unparalleled access to healthcare resources in parts where conventional healthcare infrastructure may not be so well-developed.
This wide diffusion of smartphones will be particularly impactful regarding women's health, where digital health solutions can be accessed via mobile applications that provide them with vital information, monitoring, and services right at their fingertips.
Another positive aspect of the diffusion of smartphones is the accessibility of mobile health (mHealth) applications specifically designed for women. For example, menstruation-tracking apps like Clue and Flo reached huge popularity; by 2023, Clue already had more than 12 million users worldwide.
These applications track menstrual health but also provide information on fertility, pregnancy, and general well-being, thus allowing for self-management of health. Telemedicine services are also facilitated by smartphone penetration. The trend is much on the rise in emerging markets, too.
For instance, in the case of India, smartphone penetration attained 54%, with a considerable segment of active users accessing health services through mobile applications. According to estimates by Practo, an Indian health technology firm, 40% of its total users were females who sought teleconsultations and digital prescriptions via their smartphones.
Growth of FemTech startups is a major trend in the market
FemTech, a word that combines female and technology, refers to software, diagnostics, products, and services that deploy technology for the care of women's health. This growth depicts an increasing awareness of women's health and the potential the market holds.
FemTech startups are leading the way with innovative solutions in reproductive health, pregnancy and nursing care, menstrual health, menopause, and sexual wellness. German-based start name Clue, for example, provides one of the best-known menstrual health apps, enabling users to view personalized cycle predictions, among other health insights.
Another well-known startup is Maven Clinic, which provides a virtual care platform with women's and family health considerations, from fertility support to post-natal care. Maven Clinic has raised over USD 300 million in funding, showing very clearly the demand for such focused platforms.
These products are designed with a deep understanding of specific health challenges that women face, offering convenience and improved outcomes. Another factor driving the growth of FemTech has been the increasing focus on gender-specific health research and the resultant pressure for more inclusive healthcare solutions.
Even as half of the population of the world, healthcare has often neglected women's specific needs throughout history. These startups in FemTech bridge that gap by providing much focused solutions that enhance the quality of life for women.
Limited access to digital health solutions in rural areas can hinder market growth
The major restraint in the women digital health solution market is limited access to digital health solutions in rural regions. Most rural areas face inappropriate digital infrastructure, a lack of high-speed internet facilities, and a shortage of healthcare centers.
These problems diminish the potential adoption of digital health technologies or their effective application in giving women substantial benefits. But most importantly, this limited connectivity system diminishes access to digital health platforms, apps, and telemedicine crucial for women's health.
Besides, the unavailability of health facilities in the rural areas further aggravates the situation. For instance, WHO reports that one physician serves 10,000 people in the rural regions in Africa, while in urban areas, this number is 30 physicians per 10,000.
This, in turn, means that even when the digital health solutions are available, probably there would not be enough healthcare professionals to guide and support women toward using the technology effectively. The discrepancy may be partly explained by limited access to digital health tools, which allow for virtual consultations, continuous health monitoring, and early diagnosis.
Many of these can be addressed by focused efforts at various levels to improve digital infrastructure in rural areas, enhance the much-needed training for healthcare workers, and develop low-bandwidth digital health solutions that can be accessed despite weak internet connectivity.
Principal Consultant
The Women Digital Health Solutions industry recorded a CAGR of 6.9% between 2019 and 2023. According to the industry, Women Digital Health Solutions generated USD 2,607.4 million in 2023, up from USD 1,823.7 million in 2019.
Historically, women's health was often neglected in medical research and treatment as very limited attention was paid to them, and access to suitable solutions was restricted. The trend now has changed to more personalized care, with more digital solutions for specific needs, applying technology to improve health outcomes.
The growth of the women's digital health solutions market is driven by increasing health awareness, growing demand for personalized care, and advancement in the field of technology. This growth evidences an increasing trend of integrating digital tools into health service delivery.
Other causes of growth include increased awareness of specialized health needs. This makes people to seek digital means of getting personalized care and support for reproductive health, mental well-being, and other ongoing health issues. The greater the awareness among women regarding the benefits of focused digital tools, the greater the demand.
Improvement in technology, including wearable devices and mobile apps, actually empowers women with continuous real-time data about their physiological parameters, with specific recommendations based on this data, and greatly helps them manage their health more proactively, thus contributing to improved access and quality of healthcare overall.
Companies in the Tier 1 sector account for 25.6% of the global market, ranking them as the dominant players in the industry. Tier 1 player offer a wide range of products, have an established industry presence, offer continuous innovation, and have a significant influence in the field.
Having financial resources that enables them to enhance their research and development efforts and expand into new markets. A strong brand recognition and a loyal customer base provide them with a competitive advantage. Prominent companies within Tier 1 include HeraMED Ltd, iSono Health Inc. and Biowink GmbH.
Tier 2 players dominate the industry with a 28.7% market share. Tier 2 firms have a strong focus on a specific technology and a substantial presence in the industry, but they have less influence than Tier 1 firms. The players are more competitive when it comes to pricing and target niche markets.
New products and services will also be introduced into the industry by Tier 2 companies. Tier 2 companies include Chiaro Technology Ltd., Natural Cycles USA Corp., Ava AG, and NURX, Inc.
Compared to Tiers 1 and 2, Tier 3 companies have smaller revenue spouts and less influence. Those in Tier 3 have smaller work force and limited presence across the globe. Prominent players in the tier 3 category are Athena Feminine Technologies, Inc., MobileODT Ltd., Lucina Health and others
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the women digital health solutions market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East and Africa (MEA), is provided.
The USA is anticipated to remain at the forefront in North America through 2034. China is projected to witness a CAGR of 12.6% from 2024 to 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| USA | 3.9% |
| Germany | 3.9% |
| France | 6.4% |
| China | 12.6% |
| India | 14.3% |
| South Korea | 9.9% |
Germany’s women digital health solutions market is poised to exhibit a CAGR of 3.9% between 2024 and 2034. The Germany holds highest market share in the European market.
The strong emphasis on precision medicine and a healthy regulatory environment that encourages digital health innovation is a major growth factor in Germany. The Digital Health Care Act, known as DVG, plays a very important role has allowed doctors to prescribe digital health applications, with reimbursement provided by health insurance.
The law supports the integration of cutting-edge digital tools into mainstream healthcare care to make innovations accessible and economically viable for patients.
In addition, Germany has a very high and increasing share of elderly citizens, and such a high standard of healthcare has been increasing the demand for more personalized digital health solutions, according to specific needs resulting from gender.
Areas like reproductive health management, menopause management, and general wellness are increasingly dealt with on digital platforms, signaling an ever-better appreciation of a need for technology-driven interventions. The market, therefore, moves in conjunction with the encouraging regulations and changing needs for health care.
The USA market is anticipated to grow at a CAGR of 3.9% throughout the forecast period.
Several factors contribute to the growth of the USA market, major among them being the increase in the prevalence of women's health disorders, such as endometriosis and polycystic ovary syndrome.
This has driven the adoption of the use of digital health solutions due to the high prevalence of females with health problems. In light of these health conditions, the demand for digital toolsets that can provide management and support on a personalized basis becomes so necessary.
It has been estimated that, in the USA, PCOS affects 6-12% of women of reproductive age, or approximately 5 million women. Since the diagnostic criteria and population studied often vary, prevalence estimates do differ. Indeed, PCOS is a primary cause of infertility but also frequently co-occurs with other health conditions, such as diabetes, cardiovascular problems, and mental health disorders.
Innovative solutions like mobile health applications help with symptom and menstrual cycle tracking and access to telehealth consultations. These digital platforms offer convenience, real-time monitoring, and tailored recommendation features that are valuable as more various health challenges arise. The upsurge in demand due to an increased requirement for advanced digital health solutions, therefore, propels market growth in the USA
China is expected to show a CAGR of 12.6% over the forecast period and the country dominated the East Asia market in 2023
The rapid penetration of smartphones and high-speed internet across the country is driving the expansion of digital health platforms. With more people accessing smartphones and high-speed internet, they are readily able to use health applications and access health services online. This will make it easy to access health information, schedule appointments, and receive medical advice even from home.
Smartphones come with many health apps, ranging from menstrual cycle tracking applications to chronic condition management and health tips. High-speed internet ensures this works without glitches, since it operates at efficient speeds. Some of the other key benefits are telemedicine, allowing patients to consult with a doctor over video calls or messaging, hence needing to physically visit clinics or hospitals less.
The convenience accorded to citizens facilitates access to specific health support for women, ease in healthcare service delivery, and therefore more convenience. Overall, the pervasiveness of these technologies contributes to increased effectiveness and penetration of digital health solutions across China.
A description of the leading segments in the industry is provided in this section. The mobile apps segment is expected to hold 46.5% of the value share in 2024.
| Type | Mobile Apps |
|---|---|
| Value Share (2024) | 46.5% |
The mobile apps segment is expected to dominate the market in terms of revenue, accounting for almost 46.5% of the market share in 2024.
Conveniences and access have been some of the major reasons that have led to mobile apps' leading positions in the market: making it easier for women to track different health aspects, menstrual cycles, pregnancy, and overall wellness.
Another advantage of using mobile apps is that it offers a level of privacy. This empowers women to manage their health in a comfortable environment. Mobile apps variety of features such as user-friendly interfaces, educational resources, reminders, etc. which increase adherence to the health goal.
Apart from the above demand side factor various supply side factors boost the adoption of mobile apps. Mobile apps have lower initial investment and operational costs compared to hardware development. The company can seamlessly update and get feedback directly from the end user. The covid-19 pandemic has highlighted the importance of at-home healthcare which have pushed the adoption of digital solutions.
| Application | Reproductive health |
|---|---|
| Value Share (2024) | 28.5% |
The reproductive health segment is expected to dominate the market in terms of revenue, accounting for almost 28.5% of the market share in 2024.
The reproductive health segment is likely to hold the major share of the women's digital health market, due to increasing awareness and high disease burden related to reproductive health. A considerable percentage of women are affected by diseases like PCOS, endometriosis, and infertility, which, in turn, creates demand for specific digital solutions addressing their needs.
Fertility tracking apps, ovulation monitors, and telehealth consultations are innovative solutions that have been introduced, offering them much-needed support and personalized care. Further, the focus of society on family planning and maternal health is an added cog in increasing demand for accessible, technology-driven solutions. These factors make reproductive health a central and rapidly growing segment within the market.
The market for joint women digital health solutions is extremely dispersed. Companies are constantly focusing on means to increase their revenue. Key players in the women digital health solutions market are leveraging several growth strategies. They focus on expanding product portfolios with innovative solutions such as AI-driven diagnostics and personalized health management tools.
Companies are also pursuing global market expansion by targeting emerging economies with tailored solutions. Additionally, they are implementing aggressive marketing campaigns and utilizing data analytics to better understand and address women’s unique health needs.
Recent Industry Developments in the Women Digital Health Solutions Market
In terms of type, the industry is segregated into mobile apps, wearable devices, diagnostic tools, and other types.
In terms of application, the industry is segmented into reproductive health, pregnancy & nursing care, pelvic care, and general healthcare & wellness.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, the Middle East, and Africa have been covered in the report.
Women digital health solutions industry is expected to increase at a CAGR of 12.6% between 2024 and 2034.
The mobile apps segment is expected to occupy a 46.5% market share in 2024.
The market for women digital health solutions is expected to reach USD 9,618.9 million by 2034.
The United States is forecast to see a CAGR of 3.9% during the assessment period.
The key players in the women digital health solutions industry include HeraMED Ltd, iSono Health Inc., Biowink GmbH, Chiaro Technology Ltd., Natural Cycles USA Corp., Ava AG, NURX, Inc., Athena Feminine Technologies, Inc., MobileODT Ltd., Lucina Health, Thirty Madison, Nurx Inc., UE LifeSciences Inc., Biowink GmbH, Flo Health Inc. and Maven Clinic Co.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. By Type
5.2. By Application
5.3. By Region
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Type
6.1. Mobile Apps
6.2. Wearable Devices
6.3. Diagnostic Tools
6.4. Other Types
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application
7.1. Reproductive Health
7.2. Pregnancy & Nursing Care
7.3. Pelvic Care
7.4. General Healthcare & Wellness
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
8.1. North America
8.2. Latin America
8.3. East Asia
8.4. South Asia and Pacific
8.5. Western Europe
8.6. Eastern Europe
8.7. Middle East and Africa
9. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
10. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
11. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Sales Forecast 2024 to 2034 by Type, and Application for 30 Countries
17. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
18. Company Profile
18.1. HeraMED Ltd
18.2. iSono Health Inc.
18.3. Biowink GmbH
18.4. Chiaro Technology Ltd.
18.5. Natural Cycles USA Corp.
18.6. Ava AG
18.7. NURX, Inc.
18.8. Athena Feminine Technologies, Inc.
18.9. MobileODT Ltd.
18.10. Lucina Health
18.11. Thirty Madison
18.12. Nurx Inc.
18.13. UE LifeSciences Inc.
18.14. Biowink GmbH
18.15. Flo Health Inc.
18.16. Maven Clinic Co.
Explore Healthcare Insights
View Reports
Women Digital Health Solutions Market
